World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
12067
World Ranking
3258
National Ranking
280

Tomáš Hanke publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tomáš Hanke sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 247 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tomáš Hanke D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tomáš Hanke sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tomáš Hanke is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on immunology, microbiology, and medicine, with a significant concentration on virology, immunology, infectious diseases, molecular biology, and epidemiology. This multidisciplinary approach supports investigations into viral infections, immune responses, and therapies.

Their work covers important topics including HIV research and treatment, vaccines and immunoinformatics approaches, immune cell function and interaction, HIV/AIDS research and interventions, HIV/AIDS drug development and treatment, virus-based gene therapy research, and studies on cytomegalovirus and herpesvirus.

Hanke has contributed extensively to the scientific literature, with notable recent publications such as:

  • Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial (2020), published in The Lancet
  • HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02) (2020), published in Frontiers in Immunology
  • Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial (2022), published in Nature Medicine
  • Gut microbiome signatures linked to HIV-1 reservoir size and viremia control (2022), published in Microbiome
  • MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans (2020), published in Science Translational Medicine

Frequent collaborators in Hanke's research include Edmund G. Wee, Christian Brander, Alison Crook, Lucy Dorrell, and Beatriz Mothe.

Hanke's research has been published repeatedly in certain venues, which include:

  • Vaccines
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Vaccines
  • The Lancet Microbe

The scientist's work integrates aspects of immunology and microbiology with medicine, producing insights relevant to HIV/AIDS treatment and vaccine development. Their contributions span both clinical trials and immunological studies, shaping understanding of viral reservoirs, vaccine safety and immunogenicity, and immune system interactions in the context of viral infections.

Best Publications

  • Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

    Jörg Schneider;Sarah C. Gilbert;Tom J. Blanchard;Tomas Hanke

  • Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

    Tomas Hanke;Rachel V. Samuel;Tom J. Blanchard;Veronica C. Neumann

  • Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen

    Todd M. Allen;Thorsten U. Vogel;Deborah H. Fuller;Bianca R. Mothé

  • HIV vaccines 1983-2003.

    Andrew J McMichael;Tomas Hanke

  • Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

    Nilu Goonetilleke;Stephen Moore;Len Dally;Nicola Winstone

  • Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

    Sven Létourneau;Eung-Jun Im;Tumelo Mashishi;Choechoe Brereton

  • Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

    Tomás Hanke;T J Blanchard;J Schneider;Carolyn M Hannan

  • A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

    Matilu Mwau;Inese Cebere;Julian Sutton;Priscilla Chikoti

  • Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

    Tomas Hanke;Andrew J. McMichael

  • Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1

    Nicola Borthwick;Tina Ahmed;Beatrice Ondondo;Peter Hayes

  • Crystal structure of a soluble CD28-Fab complex

    E J Evans;R M Esnouf;R Manso-Sancho;Gilbert Rjc.

  • Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.

    Tomas Hanke;Paul Szawlowski;Richard E. Randall

  • DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice

    Tomáš Hanke;Jörg Schneider;Sarah C. Gilbert;Adrian V.S. Hill

  • Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.

    Inese Cebere;Lucy Dorrell;Helen McShane;Alison Simmons

  • Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1

    Louise A Johnson;Suneale Banerji;William Lawrance;Uzi Gileadi

  • The quest for an AIDS vaccine: is the CD8 + T-cell approach feasible?

    Andrew McMichael;Tomâs Hanke

  • Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

    Tomáš Hanke;Nilu Goonetilleke;Andrew J. McMichael;Lucy Dorrell

  • Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS.

    Tomáš Hanke;Andrew McMichael

  • Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.

    Tomáš Hanke;Veronica C Neumann;Tom J Blanchard;Paul Sweeney

  • Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

    Barry S. Peters;Walter Jaoko;Eftyhia Vardas;George Panayotakopoulos

Frequent Co-Authors

Andrew J. McMichael
Andrew J. McMichael University of Oxford
Geoffrey L. Smith
Geoffrey L. Smith University of Oxford
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory
Tao Dong
Tao Dong University of Oxford
Sarah Rowland-Jones
Sarah Rowland-Jones University of Sheffield
Magdalena Plebanski
Magdalena Plebanski RMIT University
Walter Jaoko
Walter Jaoko University of Nairobi
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Christopher P. Conlon
Christopher P. Conlon University of Oxford
John Frater
John Frater University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in branching out from Immunology, healthcare offers a variety of online degree options that align well with advancing medical knowledge. Nursing professionals, for instance, can explore some of the cheapest psych np programs to specialize in psychiatric care with cost-efficient options.

Career advancement often correlates with earning potential. According to recent data on dnp salary, Doctor of Nursing Practice graduates see variations in income depending on location, which is important for students considering investment in education.

For nurse practitioners aiming for more acute settings, transitioning through acnp programs can be a strategic move. These programs prepare practitioners for the high demands of acute care facilities.

Additionally, accelerated options exist for those looking to fast-track their career shift, such as the well-regarded accelerated fnp programs. These cater to students who want to quickly gain Family Nurse Practitioner certification online.

Best Scientists Citing Tomáš Hanke

Trending Scientists

Recently Published Articles